Holen Sie sich die Stockscreener-App
97.85
1.17%
1.13
Handel nachbörslich:
97.85
Insmed Inc Aktie (INSM) Neueste Nachrichten
Monashee Investment Management LLC Acquires Shares of 50,000 Insmed, Inc. $INSM - MarketBeat
A Blueprint For Addressing Underserved Patient Populations - Clinical Leader
Nasdaq-100 Index® June 2026 Quarterly Changes - GlobeNewswire Inc.
INSM Stock Dips In Extended Trading After Experimental Skin Disease Drug Fails In Study - Stocktwits
BofA Securities Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $214 - Moomoo
Insmed stock hits 52-week low at 90.85 USD By Investing.com - Investing.com Nigeria
Daily Brief Health Care: Laurus Labs, Ascendis Pharma, GSK , Incyte Corp, Insmed Inc, Johnson & Johnson, Kardigan, LogicMark, Parabilis Medicines, Solventum and more - Smartkarma
Insmed slides 7.9% as risk-off tape collides with pipeline-focused positioning ahead of TPIP data - Quiver Quantitative
[Form 4] INSMED Inc Insider Trading Activity - Stock Titan
Insmed stock hits 52-week low at 90.85 USD - Investing.com
Stock Traders Purchase High Volume of Call Options on Insmed (NASDAQ:INSM) - MarketBeat
Cantor Fitzgerald reiterates Insmed stock rating on TPIP data outlook - Investing.com UK
Cantor Fitzgerald reiterates Insmed stock rating on TPIP data outlook By Investing.com - Investing.com Australia
GW&K Investment Management LLC Reduces Position in Insmed, Inc. $INSM - MarketBeat
Axiom Investors LLC DE Has $44.53 Million Position in Insmed, Inc. $INSM - MarketBeat
Insmed Inc stock (US4576693075): pipeline update and growth story in rare diseases - AD HOC NEWS
INSM: Brensocatib’s stellar launch and expanding pipeline set the stage for sustained growth - TradingView
Insmed Inc at Goldman Sachs Healthcare Conference Transcript - GuruFocus
INSM Maintained by JP Morgan -- Price Target Lowered to $179 - GuruFocus
Insmed (INSM) Remains a Strong Buy Despite Recent Stock Decline - GuruFocus
William Lewis files Form 144 — INSM insider sale notice (INSM) - Stock Titan
Insmed’s New Lung Disease Study Data A Win For Company, Says Analyst - Stocktwits
JPMorgan Chase & Co. Cuts Insmed (NASDAQ:INSM) Price Target to $179.00 - MarketBeat
Is Insmed (INSM) The Best Healthcare Stock to Buy Now? - Yahoo Finance
Roth MKM Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $212 - Moomoo
ING Groep NV Sells 250,555 Shares of Insmed, Inc. $INSM - MarketBeat
Fiera Capital Corp Raises Stock Position in Insmed, Inc. $INSM - MarketBeat
Clearbridge Investments LLC Has $142.54 Million Stock Holdings in Insmed, Inc. $INSM - MarketBeat
Daiwa Securities Group Inc. Acquires 34,648 Shares of Insmed, Inc. $INSM - MarketBeat
Fjarde AP Fonden Fourth Swedish National Pension Fund Purchases Shares of 50,500 Insmed, Inc. $INSM - MarketBeat
INSM, FSLR, APTV: Dreaded Death Cross Has Formed On These Stocks — What It Means For Investors - Stocktwits
Operating income of Insmed Incorporated – XETR:IM8N - TradingView
Return on equity % of Insmed Incorporated – XETR:IM8N - TradingView
Insmed Incorporated Balance Sheet – XETR:IM8N - TradingView
Is Insmed's (INSM) Brensocatib Momentum Quietly Reframing Its Respiratory Growth Narrative? - Yahoo Finance
Harvest Fund Management Co. Ltd Acquires 14,454 Shares of Insmed, Inc. $INSM - MarketBeat
INSM Maintained by RBC Capital -- Price Target Lowered to $195 - GuruFocus
INSM: Director Martina Flammer reports multiple Rule 144 sales (INSM) - Stock Titan
Insmed Chair, CEO Sold Shares Worth Over $777K - TradingView
INSMED (INSM) COO sells 2,370 shares to cover RSU tax withholding - Stock Titan
Insmed (NASDAQ: INSM) CFO sells 2,404 shares to cover RSU taxes - Stock Titan
INSMED (INSM) legal chief sells 2,159 shares to cover RSU tax - Stock Titan
Insmed (INSM) CMO sells 4,424 shares for tax withholding under plan - Stock Titan
Insmed Brinsupri Shows Strong Physician Conviction, Early Launch Momentum, RBC Says - Moomoo
RBC Capital Adjusts Insmed Price Target to $195 From $205, Maintains Outperform Rating - Moomoo
RBC Capital lowers Insmed stock price target to $195 on model refinement - Investing.com UK
Insmed Reports Inducement Grants under NASDAQ Listing Rule 5635(4) - marketscreener.com
RBC Capital lowers Insmed stock price target to $195 on model refinement By Investing.com - Investing.com South Africa
Insmed earnings up next: Can Brinsupri sustain blockbuster launch? By Investing.com - Investing.com Nigeria
UBS Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $166 - Moomoo
Insmed (INSM) Grants Equity Awards to New Employees Amid Growth Phase - GuruFocus
Insmed CEO William Lewis sells $1.47m in company stock - Investing.com
Insmed Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - TradingView
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - marketscreener.com
103 new hires at Insmed get stock, options inducement grants - Stock Titan
1.04%
0.76%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):